3-hydroxybutyric acid has been researched along with ADPKD in 1 studies
3-Hydroxybutyric Acid: BUTYRIC ACID substituted in the beta or 3 position. It is one of the ketone bodies produced in the liver.
3-hydroxybutyric acid : A straight-chain 3-hydroxy monocarboxylic acid comprising a butyric acid core with a single hydroxy substituent in the 3- position; a ketone body whose levels are raised during ketosis, used as an energy source by the brain during fasting in humans. Also used to synthesise biodegradable plastics.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Ten autosomal dominant PKD (ADPKD) patients with rapid disease progression were enrolled at visit V1 and initially maintained a carbohydrate-rich diet." | 3.30 | RESET-PKD: a pilot trial on short-term ketogenic interventions in autosomal dominant polycystic kidney disease. ( Arjune, S; Grundmann, F; Heinrich Lindemann, C; Meyer, F; Müller, RU; Oehm, S; Schmidt, J; Siedek, F; Steinke, K; Todorova, P; Weimbs, T; Wöstmann, F, 2023) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Oehm, S | 3 |
| Steinke, K | 3 |
| Schmidt, J | 3 |
| Arjune, S | 3 |
| Todorova, P | 3 |
| Heinrich Lindemann, C | 3 |
| Wöstmann, F | 3 |
| Meyer, F | 3 |
| Siedek, F | 3 |
| Weimbs, T | 3 |
| Müller, RU | 3 |
| Grundmann, F | 3 |
1 trial available for 3-hydroxybutyric acid and ADPKD
| Article | Year |
|---|---|
RESET-PKD: a pilot trial on short-term ketogenic interventions in autosomal dominant polycystic kidney disease.
Topics: 3-Hydroxybutyric Acid; Acetone; Animals; Disease Progression; Glomerular Filtration Rate; Kidney; Pi | 2023 |
RESET-PKD: a pilot trial on short-term ketogenic interventions in autosomal dominant polycystic kidney disease.
Topics: 3-Hydroxybutyric Acid; Acetone; Animals; Disease Progression; Glomerular Filtration Rate; Kidney; Pi | 2023 |
RESET-PKD: a pilot trial on short-term ketogenic interventions in autosomal dominant polycystic kidney disease.
Topics: 3-Hydroxybutyric Acid; Acetone; Animals; Disease Progression; Glomerular Filtration Rate; Kidney; Pi | 2023 |
RESET-PKD: a pilot trial on short-term ketogenic interventions in autosomal dominant polycystic kidney disease.
Topics: 3-Hydroxybutyric Acid; Acetone; Animals; Disease Progression; Glomerular Filtration Rate; Kidney; Pi | 2023 |
RESET-PKD: a pilot trial on short-term ketogenic interventions in autosomal dominant polycystic kidney disease.
Topics: 3-Hydroxybutyric Acid; Acetone; Animals; Disease Progression; Glomerular Filtration Rate; Kidney; Pi | 2023 |
RESET-PKD: a pilot trial on short-term ketogenic interventions in autosomal dominant polycystic kidney disease.
Topics: 3-Hydroxybutyric Acid; Acetone; Animals; Disease Progression; Glomerular Filtration Rate; Kidney; Pi | 2023 |
RESET-PKD: a pilot trial on short-term ketogenic interventions in autosomal dominant polycystic kidney disease.
Topics: 3-Hydroxybutyric Acid; Acetone; Animals; Disease Progression; Glomerular Filtration Rate; Kidney; Pi | 2023 |
RESET-PKD: a pilot trial on short-term ketogenic interventions in autosomal dominant polycystic kidney disease.
Topics: 3-Hydroxybutyric Acid; Acetone; Animals; Disease Progression; Glomerular Filtration Rate; Kidney; Pi | 2023 |
RESET-PKD: a pilot trial on short-term ketogenic interventions in autosomal dominant polycystic kidney disease.
Topics: 3-Hydroxybutyric Acid; Acetone; Animals; Disease Progression; Glomerular Filtration Rate; Kidney; Pi | 2023 |